Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.70 |
| ▸ | CA9 | Q16790 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GLS | O94925 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | SHH | Q15465 | 3/20 | 0.35 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.31 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789754 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL15577080 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL22759100 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL1539181 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL1539182 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL8465823 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL23438526 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL22985856 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL21983880 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL21886528 | 1.00 | CA1 (0.70) | CA1CA9ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) | 2025-02-06 | — | — | US | disclosed |
| EP-4433451-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | Ecole Nationale Supérieure de Chimie de Rennes (FR) | 2024-09-25 | — | — | EP | disclosed |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | UMICORE AG & CO. KG (DE) | 2024-04-16 | — | — | US | disclosed |
| US-11807617-B2 | Highly efficient synthesis of Z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-11-07 | — | — | US | disclosed |
| WO-2023088919-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2023-05-25 | — | — | WO | disclosed |
| US-20230159426-A1 | LILY OF THE VALLEY ODORANT | FIRMENICH & CIE (CH) | 2023-05-25 | — | — | US | disclosed |
| CN-110536748-B | Highly efficient synthesis of Z-macrocycles using stereosretentive ruthenium-based metathesis catalysts | 加利福尼亚技术学院 | 2023-04-04 | — | — | CN | disclosed |
| US-20220055025-A1 | REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METHATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2022-02-24 | — | — | US | disclosed |
| EP-3167031-B1 | ISOMERS MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20050131233-A1 | Ruthenium compounds, their production and use | UNIVERSITY OF OTTAWA (CA) | 2005-06-16 | — | — | US | disclosed |
| WO-2005012315-A1 | RUTHENIUM COMPOUNDS, THEIR PRODUCTION AND USE | UNIVERSITY OF OTTAWA (CA) | 2005-02-10 | — | — | WO | disclosed |
| EP-0975622-B1 | SELECTIVE OLEFIN METATHESIS OF BIFUNCTIONAL OR POLYFUNCTIONAL SUBSTRATES IN COMPRESSED CARBON DIOXIDE AS REACTION MEDIUM | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-10-09 | — | — | EP | disclosed |
| EP-0908455-B1 | Macrocycles | GIVAUDAN SA (CH) | 2002-07-10 | — | — | EP | disclosed |
| US-6348551-B1 | CATALYTIC CYCLIZATION OF ALKENES AND ALKYNES; ESTERIFICATION, LACTONIZATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-02-19 | — | — | US | disclosed |
| US-6255276-B1 | MUSK MACROMOLECULE | GIVAUDEN ROURE (INTERNATIONAL) S.A. (CH) | 2001-07-03 | — | — | US | disclosed |
| EP-1036081-A1 | HETEROCYCLYL LIGAND CONTAINING RUTHENIUM AND OSMIUM CATALYSTS | Ciba SC Holding AG (CH) | 2000-09-20 | — | — | EP | disclosed |
| US-5936100-A | METAL CARBENE COMPLEXES OF RUTHENIUM OR OSMIUM | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1999-08-10 | — | — | US | disclosed |
| WO-1999029701-A1 | HETEROCYCLYL LIGAND CONTAINING RUTHENIUM AND OSMIUM CATALYSTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-06-17 | — | — | WO | disclosed |
| EP-0908455-A1 | Macrocycles | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1999-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131233-A1 | Ruthenium compounds, their production and use | TIPARP, SPR, PARP14 | CA1 3007/4885CA9 2903/4885ALDH1A1 775/4885 |
| US-20230159426-A1 | LILY OF THE VALLEY ODORANT | ACLY, PIR, NOX5 | CA1 2818/4885CA9 2054/4885ALDH1A1 903/4885 |
| US-20220055025-A1 | REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METHATHESIS CATALYSTS | MDK, MTR, MUSK | CA1 3731/4885CA9 4627/4885ALDH1A1 1302/4885 |
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | SQLE, SYMPK, FDFT1 | CA1 3854/4885CA9 3932/4885ALDH1A1 1256/4885 |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | SYMPK, MDK, HCK | CA1 3425/4885CA9 4333/4885ALDH1A1 3382/4885 |
| US-11807617-B2 | Highly efficient synthesis of Z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts | ZKSCAN2, ZYX, SPR | CA1 1763/4885CA9 1898/4885ALDH1A1 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.